世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039169

2024年のPOC感染症検査市場:2023年のサプライヤーシェア、2023〜2028年の診察室/グループ診療所、緊急治療室、外来診療センター、手術センター、出産センターの検査件数と売上セグメント予測 - 技術動向、機器レビュー、サプライヤーの機会

VPGMarketResearch

2024 POC Infectious Disease Testing Market: 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers --Technology Trends, Instrumentation Review, Opportunities for Suppliers

発刊日 2024/07/01

言語英語

体裁PDF

ライセンス/価格

0000039169

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

この最新レポートは、POC感染症検査市場の動向、ダイナミクス、規模、成長、規制要件、技術動向、競合環境、機器・消耗品サプライヤーの新たなビジネスチャンスなどを包括的に分析しています。本レポートはセクション別に提供されており、特定の情報ニーズや予算に合わせてカスタマイズすることも可能です。本レポートは、診断製品サプライヤーが世界のPOC感染症検査市場において効果的な事業戦略、研究開発戦略、マーケティング戦略を策定するのに役立ちます。

論理的根拠

病院に対する経済的圧力の増大、診断技術の進歩、供給業者や医師間の競争の激化、消費者の要求の変化と相まって、診断検査は病院や商業検査所から患者に近いところへとシフトしてきています。

市場セグメンテーション分析

  • 5つのPOC市場セグメントについて、その動態、傾向、構造、規模、成長、主要サプライヤーなどを含めたレビュー
  • 市場セグメント別の主要な感染症検査の5年間の検査量と試薬販売予測
    市場セグメント別
      ◇ 診察室/グループ診療所
      ◇ 緊急治療室
      ◇ 外来診療センター
      ◇ 手術センター
      ◇ 出産センター

    売上と市場シェアの分析

    • 主要な感染症診断試薬および機器サプライヤーの市場シェア

    現在の製品と新製品

    • POC検査の現場で実施された感染症診断検査の分析
    • 現在販売されているもの、開発中のものの両方を含む主要な感染症検査分析装置の動作特性、機能、販売価格などのレビュー

    技術レビュー

    • POC検査のための新しい技術とその応用
    • 凝固検査技術および製品を開発または販売している企業の包括的なリスト(アッセイ別)

    競争力評価

    • 主要サプライヤーおよび新興市場参入企業の評価(売上高、製品ポートフォリオ、マーケティング戦略、合弁事業、研究開発中の新製品など)

    戦略的推奨事項

    • 今後5年間で市場への大きな訴求力を持つ可能性のある、新しい感染症検査機器および試薬システムの具体的な機会
    • POC 検査製品の設計基準
    • 代替のビジネス拡大戦略
    • 潜在的な市場参入障壁およびリスク

    方法論

    このレポートは、最近の技術およびビジネス出版物、メーカーの製品資料、業界アナリストレポート、VPGMarketResearch社独自のデータファイルのレビューなど、一次情報源と二次情報源の組み合わせに基づいています。

    レポート詳細

    目次

    Table of Contents
    Introduction
    Executive Summary
    Rationale for Testing Decentralization
    1. Overview
    2. Regulatory Trends
    3. Economic Trends
    4. Demographic Trends
    5. Technological Trends
    6. Social Trends
    7. Quality of Care
    8. Defensive Medicine
    9. Quality Control Issues
    Worldwide Market and Technology Overview
    1. AIDS
    2. Adenovirus
    3. Campylobacter
    4. Candida
    5. Chlamydia
    6. Clostridium Difficile
    7. Cytomegalovirus
    8. Enteroviruses
    9. Epstein-Barr Virus
    10. Gonorrhea
    11. Helicobacter Pylori
    12. Hepatitis
    a. Hepatitis A
    b. Hepatitis B
    c. Hepatitis C
    d. Hepatitis D
    13. Herpes Simplex Virus
    14. Human Herpes Virus-6 (HHV-6)
    15. Influenza Viruses
    16. Legionella
    17. Lyme Disease
    18. Measles (Rubeola)
    19. Meningitis
    20. Mononucleosis
    21. Mumps
    22. Mycoplasma
    23. Papillomaviruses
    24. Pneumonia
    25. Respiratory Syncytial Virus (RSV)
    26. Rheumatoid Arthritis
    27. Rotavirus (Reovirus)
    28. Rubella (German Measles)
    29. Salmonellosis
    30. Shigellosis
    31. Staphylococcus Aureus
    32. Streptococci
    33. Syphilis
    Instrumentation: Infectious Disease Analyzers Manufactured by:
    - Abbott
    - Beckman Coulter/Danaher
    - bioMeriuex
    - Ortho-Clinical Diagnostics
    - Roche
    - Siemens
    - Tosoh
    - Wallac, and other suppliers
    Current and Emerging Technologies
    1. Monoclonal Antibodies
    2. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
    - Overview
    - ELISA
    - Dot Immunobinding Assays
    - Capillary Immunoassays
    U.S.A.
    - Particle-Membrane Capture Immunoassay
    - Enzyme Amplification
    c. Fluorescent Immunoassays
    - Fluorescent Polarization
    - Time-Resolved Pulse Fluorescence
    d. Luminescence
    - Chemiluminescence
    - Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
    3. Dry Chemistry
    4. Biosensors
    5. IT and Automation
    6. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
    - Polymerase Chain Reaction
    - Ligase Chain Reaction
    - Branched DNA
    - Q-Beta Replicase
    - Strand Displacement Activation
    - Self-Sustained Sequence Replicase
    A. Market Overview
    1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
    - PPO
    - HMO
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
    - More Chronic Illness
    - Disease Incidence
    - Susceptibility to latrogenesis
    - Multiple Illnesses Cases l.
    Laboratory Regulations
    2. Market Structure
    a. Hospitals
    b. Commercial/Private Laboratories
    C. Physician Offices/Group Practices
    1. Market Summary
    2. Market Structure
    3. Test Volume and Sales Forecasts
    D. Ancillary Hospital Locations
    1. Introduction
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
    2. Emergency Departments
    a. Market Summary
    b. Test volume and Sales Forecasts
    3. Operating and Recovery Suites
    a. Market Summary
    b. Test Volume and Sales Forecasts
    4. ICUs/CCUs
    a. Market Summary
    b. Test Volume and Sales Forecasts
    E. Cancer Clinics
    1. Introduction
    2. Market Summary
    3. Test Volume and Sales Forecasts
    F. Ambulatory Care Centers
    1. Introduction
    2. Market Summary
    3. Market Structure
    4. Test Volume and Sales Forecasts
    G. Surgery Centers
    1. Introduction
    2. Market Summary
    3. Market Structure
    4. Test Volume and Sales Forecasts
    H. Nursing Homes
    1. Introduction
    2. Market Summary
    3. Market Structure
    4. Test Volume and Sales Forecasts
    I. Birth Centers
    1. Introduction
    2. Market Summary
    3. Market Structure
    4. Test Volume and Sales Forecasts
    J. Major Suppliers’ Instrument Placements,
    Installed Base, Reagent Sales and Market Shares
    Major Product Development Opportunities
    Design Criteria for Decentralized Testing Products
    Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
    1. Marketing Approaches
    2. Product complexity
    3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types of Distributors
    7. Market Segmentation
    Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Company Profile
    - Abbott
    - Affymetrix
    - Beckman Coulter/Danaher/Cepheid
    - Becton Dickinson
    - bioMerieux
    - Bio-Rad
    - Diamedix
    - DiaSorin
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Fujifilm Wako
    - Fujirebio
    - Grifols
    - Hologic/Gen-Probe
    - Kreatech/Leica
    - Labcorp
    - Lonza
    - Qiagen
    - QuidelOrtho
    - Roche
    - Scienion
    - SeraCare
    - Siemens Healthineers
    - Takara Bio
    - Thermo Fisher

    List of Tables
    Major Companies Developing or Marketing
    AIDS Tests
    Major Companies Developing or Marketing
    Adenovirus Tests
    Major Companies Developing or Marketing
    Campylobacter Tests
    Major Companies Developing or Marketing
    Candida Tests
    Major Companies Developing or Marketing
    CMV Tests
    Major Companies Developing or Marketing
    EBV Tests
    Major Companies Developing or Marketing
    Gonorrhea Tests
    Major Companies Developing or Marketing
    Helicobacter Pylori Tests
    Major Companies Developing or Marketing
    Hepatitis Tests
    Major Companies Developing or Marketing
    Herpes Tests
    Major Companies Developing or Marketing
    Influenza Tests
    Major Companies Developing or Marketing
    Legionella Tests
    Major Companies Developing or Marketing
    Lyme Disease Tests
    Major Companies Developing or Marketing
    Measles Tests
    Major Companies Developing or Marketing
    Meningitis Tests
    Major Companies Developing or Marketing
    Mononucleosis Tests
    Major Companies Developing or Marketing
    Mumps Tests
    Major Companies Developing or Marketing
    Mycoplasma Tests
    Major Companies Developing or Marketing
    Pneumonia Tests
    Major Companies Developing or Marketing
    RSV Tests
    Major Companies Developing or Marketing
    Rotavirus Tests
    Major Companies Developing or Marketing
    Rubella Tests
    Major Companies Developing or Marketing
    Salmonella Tests
    Major Companies Developing or Marketing
    Shigella Tests
    Major Companies Developing or Marketing
    Streptococci Tests
    Major Companies Developing or Marketing
    Syphilis Tests
    U.S.A., Physician Office/Group Practice
    Laboratories Forecast by Practice Size
    U.S.A., Physician Offices/Group Practices
    Forecast by Type
    U.S.A., Office-Based Physicians
    Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices
    Infectious Disease Test Volume Forecast
    U.S.A., Physician Offices/Group Practices
    Microbiology Test Volume Forecast
    U.S.A., Physician Offices/Group Practices
    Infectious Disease Reagent and Instrument Sales Forecast
    U.S.A., Physician Offices/Group Practices
    Microbiology Reagent and Instrument Sales Forecast
    U.S.A., Ancillary Hospital Locations Estimated Number
    U.S.A., Ancillary Hospital Locations Annual Utilization
    U.S.A., Hospital Emergency Departments
    Infectious Disease Test Volume Forecast
    U.S.A., Hospital Emergency Departments
    Infectious Disease Reagent
    and Instrument Sales Forecast
    U.S.A., Ambulatory Care Centers Estimated
    Number of Facilities and Patient Visits
    U.S.A., Ambulatory Care Centers
    Most Frequent Diagnoses
    U.S.A., Ambulatory Care Centers
    Infectious Disease Test Volume Forecast
    U.S.A., Ambulatory Care Centers Microbiology
    And Serology Test Volume Forecast
    U.S.A., Ambulatory Care Centers
    Infectious Disease Reagent and Instrument Sales Forecast
    U.S.A., Ambulatory Care Centers Microbiology
    and Serology Reagent and Instrument Sales Forecast
    U.S.A., Surgery Centers Most
    Frequently Performed Procedures
    U.S.A., Surgery Centers Microbiology
    and Serology Test Volume Forecast
    U.S.A., Surgery Centers Microbiology
    And Serology Reagent and Instrument Sales Forecast
    U.S.A., Birth Centers Facilities,
    Patient Visits, and Births
    U.S.A., Birth Centers Microbiology
    and Serology Test Volume Forecast
    U.S.A., AIDS Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Chlamydia Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., CMV Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Gonorrhea Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Helicobacter Pylori Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Hepatitis Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Herpes Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Influenza Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Lyme Disease Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Mononucleosis Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Rubella Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Streptococci Testing Market
    Estimated Market Shares of Major Suppliers
    U.S.A., Syphilis Testing Market
    Estimated Market Shares of Major Suppliers

この商品のレポートナンバー

0000039169

TOP